{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:33:04Z","timestamp":1783575184127,"version":"3.55.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["825489"],"award-info":[{"award-number":["825489"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.yrtph.2026.106041","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:07:24Z","timestamp":1769616444000},"page":"106041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new biomarkers into OECD test guidelines"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9171-3692","authenticated-orcid":false,"given":"Claire","family":"Beausoleil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0460-6192","authenticated-orcid":false,"given":"Christophe","family":"Rousselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3472-1693","authenticated-orcid":false,"given":"Eren","family":"Ozcagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4858-0118","authenticated-orcid":false,"given":"Miriam N.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yrtph.2026.106041_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/js.2017-00044","article-title":"Body mass index and incident type 1 and type 2 diabetes in children and young adults: a retrospective cohort study","volume":"1","author":"Abbasi","year":"2017","journal-title":"J. Endocr. Soc."},{"issue":"9","key":"10.1016\/j.yrtph.2026.106041_bib2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1289\/ehp.11200","article-title":"In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens","volume":"116","author":"Ahn","year":"2008","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1758-5996-6-99","article-title":"Association of adipokines, leptin\/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus","volume":"6","author":"Al-Hamodi","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106041_bib4","first-page":"256","article-title":"Comparative study of overweight and Obese patients with nonalcoholic fatty liver disease","volume":"111","author":"Aller","year":"2019","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106041_bib5","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/en.2014-1952","article-title":"Bisphenol-A treatment during pregnancy in mice: a new window of susceptibility for the development of diabetes in mothers later in life","volume":"156","author":"Alonso-Magdalena","year":"2015","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.yrtph.2026.106041_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1289\/ehp.8002","article-title":"Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans","volume":"113","author":"Alonso-Magdalena","year":"2005","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1289\/ehp.8451","article-title":"The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance","volume":"114","author":"Alonso-Magdalena","year":"2006","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106041_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002069","article-title":"Pancreatic insulin content regulation by the estrogen receptor ER alpha","volume":"3","author":"Alonso-Magdalena","year":"2008","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106041_bib9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1289\/ehp.1001993","article-title":"Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring","volume":"118","author":"Alonso-Magdalena","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2026.106041_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1964684","article-title":"An overview of hormone-sensitive lipase (HSL)","volume":"2022","author":"Althaher","year":"2022","journal-title":"Sci. World J."},{"issue":"12","key":"10.1016\/j.yrtph.2026.106041_bib11","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20165646","article-title":"Non-clinical studies in the process of new drug development - part II: good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies","volume":"49","author":"Andrade","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clinbiochem.2012.11.006","article-title":"Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease","volume":"46","author":"Auguet","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.yrtph.2026.106041_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107250","article-title":"G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ER\u03b1 and ER\u03b2 in pancreatic beta cells","volume":"164","author":"Babiloni-Chust","year":"2022","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2026.106041_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116995","article-title":"Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approach","volume":"489","author":"Beausoleil","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106041_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tiv.2019.05.019","article-title":"Validation of in vitro methods for human cytochrome P450 enzyme induction: outcome of a multi-laboratory study","volume":"60","author":"Bernasconi","year":"2019","journal-title":"Toxicol. Vitro"},{"issue":"5","key":"10.1016\/j.yrtph.2026.106041_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1189\/jlb.0310153","article-title":"NF-\u03baB as a central regulator of macrophage function in tumors","volume":"88","author":"Biswas","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106041_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12263-009-0117-6","article-title":"Mouse models for the central melanocortin system","volume":"4","author":"Bolze","year":"2009","journal-title":"Gene Nutr."},{"key":"10.1016\/j.yrtph.2026.106041_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1592683","article-title":"Adipose tissue dysfunction disrupts metabolic homeostasis: mechanisms linking fat dysregulation to disease","volume":"16","author":"Bou Matar","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106041_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-013-2841-0","article-title":"Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies","volume":"56","author":"Calanna","year":"2013","journal-title":"Diabetologia"},{"issue":"Pt A","key":"10.1016\/j.yrtph.2026.106041_bib23","article-title":"Effect of subacute and prenatal DINCH plasticizer exposure on rat dams and male offspring hepatic function: the role of PPAR-\u03b1","volume":"179","author":"Campioli","year":"2019","journal-title":"Environ. Res."},{"key":"10.1016\/j.yrtph.2026.106041_bib24","article-title":"A plausibility database summarizing the level of evidence regarding the hazards induced by the exposome on children health","volume":"256","author":"Colzin","year":"2024","journal-title":"Int. J. Hyg Environ. Health"},{"key":"10.1016\/j.yrtph.2026.106041_bib25","author":"Commission"},{"issue":"7","key":"10.1016\/j.yrtph.2026.106041_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072124","article-title":"PPARs and metabolic disorders associated with challenged adipose tissue plasticity","volume":"19","author":"Corrales","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106041_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/toxsci\/kfae102","article-title":"A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment","volume":"201","author":"Corton","year":"2024","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106041_bib28","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/jn\/nxab117","article-title":"CUN-BAE index as a screening tool to identify increased metabolic risk in apparently healthy normal-weight adults and those with obesity","volume":"151","author":"Costa","year":"2021","journal-title":"J. Nutr."},{"key":"10.1016\/j.yrtph.2026.106041_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108931","article-title":"Urinary concentrations of phthalate\/DINCH metabolites and body mass index among European children and adolescents in the HBM4EU aligned studies: a cross-sectional multi-country study","volume":"190","author":"Desalegn","year":"2024","journal-title":"Environ. Int."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOL.0b013e32832ac03e","article-title":"Human C-reactive protein and the metabolic syndrome","volume":"20","author":"Devaraj","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"issue":"10","key":"10.1016\/j.yrtph.2026.106041_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102711","article-title":"The potential role of C-Reactive protein in metabolic-dysfunction-associated fatty liver disease and aging","volume":"11","author":"Ding","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.yrtph.2026.106041_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.122829","article-title":"In vitro effects of triclocarban on adipogenesis in murine preadipocyte and human hepatocyte","volume":"399","author":"Dong","year":"2020","journal-title":"J. Hazard Mater."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010231","article-title":"Screening of metabolism-disrupting chemicals on pancreatic \u03b1-Cells using in vitro methods","volume":"24","author":"Dos Santos","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.yrtph.2026.106041_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095040","article-title":"In vitro assays to identify metabolism-disrupting chemicals with diabetogenic activity in a human pancreatic \u03b2-Cell model","volume":"23","author":"Dos Santos","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yrtph.2026.106041_bib35","year":"2008"},{"key":"10.1016\/j.yrtph.2026.106041_bib36","series-title":"Annex XV report PROPOSAL FOR IDENTIFICATION OF A SUBSTANCE OF VERY HIGH CONCERN ON THE BASIS OF THE CRITERIA SET OUT IN REACH ARTICLE 57","year":"2017"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib37","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41598-024-51394-z","article-title":"Fibroblast growth factor-21 and visfatin as potential predictors for metabolic risk factors in obese children","volume":"14","author":"El-Masry","year":"2024","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.yrtph.2026.106041_bib38","doi-asserted-by":"crossref","first-page":"e1697","DOI":"10.1210\/clinem\/dgae119","article-title":"The association of cardiometabolic, diet and lifestyle parameters with plasma glucagon-like Peptide-1: an IMI DIRECT study","volume":"109","author":"Eriksen","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.yrtph.2026.106041_bib39","article-title":"Serum tumor necrosis factor alpha (TNF-\u03b1) levels in Obese and overweight adults: correlations with metabolic syndrome and inflammatory markers","volume":"16","author":"Eswar","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/M22-3078","article-title":"Prevalence and management of obesity in U.S. adults with type 1 diabetes","volume":"176","author":"Fang","year":"2023","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12876-020-01369-x","article-title":"Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study","volume":"20","author":"Fujii","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"6","key":"10.1016\/j.yrtph.2026.106041_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100214","article-title":"Exposure to bisphenol-A during pregnancy partially mimics the effects of a high-fat diet altering glucose homeostasis and gene expression in adult male mice","volume":"9","author":"Garc\u00eda-Arevalo","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.yrtph.2026.106041_bib43","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/en.2016-1390","article-title":"Maternal exposure to Bisphenol-A during pregnancy increases pancreatic \u03b2-Cell growth during early life in Male mice offspring","volume":"157","author":"Garc\u00eda-Ar\u00e9valo","year":"2016","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.yrtph.2026.106041_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tem.2009.02.002","article-title":"Role of central melanocortin pathways in energy homeostasis","volume":"20","author":"Garfield","year":"2009","journal-title":"Trends Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12902-019-0386-z","article-title":"Total adiponectin in overweight and obese subjects and its response to visceral fat loss","volume":"19","author":"Gariballa","year":"2019","journal-title":"BMC Endocr. Disord."},{"issue":"Pt 2","key":"10.1016\/j.yrtph.2026.106041_bib46","article-title":"Metabolomics in human SGBS cells as new approach method for studying adipogenic effects: analysis of the effects of DINCH and MINCH on central carbon metabolism","volume":"252","author":"Goerdeler","year":"2024","journal-title":"Environ. Res."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106041_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020476","article-title":"Enhanced GIP secretion in obesity is associated with biochemical alteration and miRNA contribution to the development of liver steatosis","volume":"12","author":"G\u00f3ralska","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106041_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.14573\/altex.2013.4.445","article-title":"In vitro and in vivo testing methods of epigenomic endpoints for evaluating endocrine disruptors","volume":"30","author":"Greally","year":"2013","journal-title":"Altex"},{"key":"10.1016\/j.yrtph.2026.106041_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.metabol.2018.01.015","article-title":"Use of BMI as the marker of adiposity in a metabolic syndrome severity score: derivation and validation in predicting long-term disease outcomes","volume":"83","author":"Gurka","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.yrtph.2026.106041_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.12688\/wellcomeopenres.14974.1","article-title":"Metabolic profiling of adolescent non-alcoholic fatty liver disease","volume":"3","author":"Hartley","year":"2018","journal-title":"Wellcome Open Res."},{"issue":"1 Suppl. l","key":"10.1016\/j.yrtph.2026.106041_bib51","first-page":"I33","article-title":"Watanabe heritable hyperlipidemic rabbit. Animal model for familial hypercholesterolemia","volume":"9","author":"Havel","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.yrtph.2026.106041_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod. Toxicol."},{"issue":"10","key":"10.1016\/j.yrtph.2026.106041_bib53","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s42255-024-01113-9","article-title":"GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management","volume":"6","author":"Holst","year":"2024","journal-title":"Nat. Metab."},{"issue":"7640","key":"10.1016\/j.yrtph.2026.106041_bib54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yrtph.2026.106041_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2350-14-54","article-title":"Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver","volume":"14","author":"Hsiao","year":"2013","journal-title":"BMC Med. Genet."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1572-0241.2005.00341.x","article-title":"The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002","volume":"101","author":"Ioannou","year":"2006","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106041_bib57","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00204-020-02784-5","article-title":"Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens","volume":"94","author":"Jacobs","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106041_bib58","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2174\/138920008786049294","article-title":"The use of metabolising systems for in vitro testing of endocrine disruptors","volume":"9","author":"Jacobs","year":"2008","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.yrtph.2026.106041_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.880818","article-title":"Candidate proficiency test chemicals to address industrial chemical applicability domains for in vitro human cytochrome P450 enzyme induction","volume":"4","author":"Jacobs","year":"2022","journal-title":"Front Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.14573\/altex.2013.3.331","article-title":"In vitro metabolism and bioavailability tests for endocrine active substances: what is needed next for regulatory purposes?","volume":"30","author":"Jacobs","year":"2013","journal-title":"Altex"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1079\/PNS2001140","article-title":"Steroid hormone receptors and dietary ligands: a selected review","volume":"61","author":"Jacobs","year":"2002","journal-title":"Proc. Nutr. Soc."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12010159","article-title":"The role of GLP-1, GIP, MCP-1 and IGFBP-7 biomarkers in the development of metabolic disorders: a review and predictive analysis in the context of diabetes and obesity","volume":"12","author":"J\u0119drysik","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.yrtph.2026.106041_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1264530","article-title":"The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response","volume":"14","author":"Jena","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106041_bib64","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1007\/s12035-018-1285-4","article-title":"Triclocarban disrupts the epigenetic status of neuronal cells and induces AHR\/CAR-Mediated apoptosis","volume":"56","author":"Kajta","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2026.106041_bib65","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/carcin\/bgv033","article-title":"Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions","volume":"36","author":"Kravchenko","year":"2015","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106041_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25040775","article-title":"An MRM-based multiplexed quantification assay for human adipokines and apolipoproteins","volume":"25","author":"Krieg","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.yrtph.2026.106041_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1126880","article-title":"Development of a reference and proficiency chemical list for human steatosis endpoints in vitro","volume":"14","author":"Kubickova","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106041_bib68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00365520903443852","article-title":"Serum chemerin and vaspin in non-alcoholic fatty liver disease","volume":"45","author":"Kukla","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.yrtph.2026.106041_bib69","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/s42255-025-01388-6","article-title":"Mitochondrial and psychosocial stress-related regulation of FGF21 in humans","volume":"7","author":"Kurade","year":"2025","journal-title":"Nat. Metab."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106041_bib70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41574-024-01059-8","article-title":"Consensus on the key characteristics of metabolism disruptors","volume":"21","author":"La Merrill","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.yrtph.2026.106041_bib71","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mce.2018.02.009","article-title":"Effects of bisphenol A on metabolism and evidences of a mode of action mediated through endocrine disruption","volume":"475","author":"Le Magueresse-Battistoni","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"10","key":"10.1016\/j.yrtph.2026.106041_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103480","article-title":"The GOLIATH project: towards an internationally harmonised approach for testing metabolism disrupting compounds","volume":"21","author":"Legler","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yrtph.2026.106041_bib73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.toxlet.2018.09.011","article-title":"Metabonomics reveals that triclocarban affects liver metabolism by affecting glucose metabolism, \u03b2-oxidation of fatty acids, and the TCA cycle in male mice","volume":"299","author":"Li","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"Pt 3","key":"10.1016\/j.yrtph.2026.106041_bib74","article-title":"Triclocarban and triclosan exacerbate high-fat diet-induced hepatic lipid accumulation at environmental related levels: the potential roles of estrogen-related receptors pathways","volume":"858","author":"Li","year":"2023","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.yrtph.2026.106041_bib75","article-title":"The gene-gene interaction of INSIG-SCAP-SREBP pathway on the risk of obesity in Chinese children","volume":"2014","author":"Liu","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"7","key":"10.1016\/j.yrtph.2026.106041_bib76","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/pedi.12730","article-title":"Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: data from the international SWEET registry","volume":"19","author":"Maffeis","year":"2018","journal-title":"Pediatr. Diabetes"},{"issue":"6","key":"10.1016\/j.yrtph.2026.106041_bib77","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3122\/jabfm.2008.06.080047","article-title":"The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes","volume":"21","author":"Mainous","year":"2008","journal-title":"J. Am. Board Fam. Med."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12920-019-0536-1","article-title":"Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients","volume":"12","author":"Margerie","year":"2019","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.yrtph.2026.106041_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.683250","article-title":"Adiponectin, leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD","volume":"8","author":"Marques","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.yrtph.2026.106041_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.129051","article-title":"Bisphenol-S and Bisphenol-F alter mouse pancreatic \u03b2-cell ion channel expression and activity and insulin release through an estrogen receptor ER\u03b2 mediated pathway","volume":"265","author":"Marroqui","year":"2021","journal-title":"Chemosphere"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106041_bib81","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00125-019-4925-y","article-title":"Oestrogen receptor \u03b2 mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells","volume":"62","author":"Martinez-Pinna","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.yrtph.2026.106041_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.780888","article-title":"Obesogens: how they are identified and molecular mechanisms underlying their action","volume":"12","author":"Mohajer","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106041_bib83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.yrtph.2026.106041_bib84","article-title":"Gamma-glutamyl transferase as a diagnostic marker of metabolic syndrome","volume":"15","author":"Naidu","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.yrtph.2026.106041_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxlet.2024.04.002","article-title":"Triclocarban induces lipid droplet accumulation and oxidative stress responses by inhibiting mitochondrial fatty acid oxidation in HepaRG cells","volume":"396","author":"Nakamura","year":"2024","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2026.106041_bib86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.metabol.2018.12.006","article-title":"Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine","volume":"92","author":"Nimptsch","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.yrtph.2026.106041_bib87","series-title":"Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2008"},{"key":"10.1016\/j.yrtph.2026.106041_bib88","series-title":"Detailed Review Paper on the State of the Science on Novel in Vitro and in Vivo Screening and Testing Methods and Endpoints for Evaluating Endocrine Disruptors","year":"2012"},{"key":"10.1016\/j.yrtph.2026.106041_bib89","series-title":"Detailed Review Paper on the Use of Metabolising Systems for in Vitro Testing of Endocrine Disruptors, OECD Series on Testing and Assessment, No. 97","year":"2014"},{"key":"10.1016\/j.yrtph.2026.106041_bib90","series-title":"New Scoping Document on in Vitro and Ex Vivo Assays for the Identification of Modulators of Thyroid Hormone Signalling, OECD Series on Testing and Assessment, No. 207","year":"2014"},{"key":"10.1016\/j.yrtph.2026.106041_bib91","series-title":"Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption, OECD Series on Testing and Assessment, No. 150","year":"2018"},{"key":"10.1016\/j.yrtph.2026.106041_bib92","series-title":"Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2018"},{"key":"10.1016\/j.yrtph.2026.106041_bib93","series-title":"Test No. 443: Extended One-Generation Reproductive Toxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2018"},{"key":"10.1016\/j.yrtph.2026.106041_bib94","series-title":"Test No. 452: Chronic Toxicity Studies, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2018"},{"key":"10.1016\/j.yrtph.2026.106041_bib95","series-title":"Detailed Review Paper on the Retinoid System, OECD Series on Testing and Assessment, No. 343","year":"2021"},{"key":"10.1016\/j.yrtph.2026.106041_bib96","series-title":"Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106041_bib97","series-title":"Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106041_bib98","series-title":"Test No. 443: Extended One-Generation Reproductive Toxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4","year":"2025"},{"issue":"8","key":"10.1016\/j.yrtph.2026.106041_bib99","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/etc.5078","article-title":"The extended amphibian metamorphosis assay: a thyroid-specific and less animal-intensive alternative to the larval amphibian growth and development assay","volume":"40","author":"Ortego","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.yrtph.2026.106041_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1401120","article-title":"Addressing chemically-induced obesogenic metabolic disruption: selection of chemicals for in vitro human PPAR\u03b1, PPAR\u03b3 transactivation, and adipogenesis test methods","volume":"15","author":"Ozcagli","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib101","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13679-025-00665-5","article-title":"Chemerin and asprosin as promising biomarkers of metabolic syndrome: a scoping review","volume":"14","author":"Ozyalcin","year":"2025","journal-title":"Curr. Obes. Rep."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib102","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jc.2005-1056","article-title":"Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance","volume":"91","author":"Pagano","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yrtph.2026.106041_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154300","article-title":"Induction of human cytochrome P450 enzyme activities by metabolism disrupting chemicals in the hepatic cell line HepaRG","volume":"519","author":"Person","year":"2026","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib104","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12902-017-0189-z","article-title":"Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural thais: a cross-sectional study","volume":"17","author":"Phosat","year":"2017","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.yrtph.2026.106041_bib105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tiv.2017.11.003","article-title":"Identification of candidate reference chemicals for in vitro steroidogenesis assays","volume":"47","author":"Pinto","year":"2018","journal-title":"Toxicol. Vitro"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib106","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib107","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1530\/EJE-09-0767","article-title":"Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training","volume":"162","author":"Ruschke","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.yrtph.2026.106041_bib18","series-title":"SCIENTIFIC ADVICE ON the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products","year":"2022"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106041_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092367","article-title":"The emerging plasticizer alternative DINCH and its metabolite MINCH induce oxidative stress and enhance inflammatory responses in human THP-1 macrophages","volume":"10","author":"Schaffert","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.yrtph.2026.106041_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107279","article-title":"Di-(2-ethylhexyl) phthalate substitutes accelerate human adipogenesis through PPAR\u03b3 activation and cause oxidative stress and impaired metabolic homeostasis in mature adipocytes","volume":"164","author":"Schaffert","year":"2022","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2026.106041_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106730","article-title":"Alternatives for the worse: molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation","volume":"156","author":"Schaffert","year":"2021","journal-title":"Environ. Int."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030865","article-title":"Circulating GLP-1 levels as a potential indicator of metabolic syndrome risk in adult women","volume":"13","author":"Seon","year":"2021","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.yrtph.2026.106041_bib112","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic messengers: tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat. Metab."},{"issue":"10 Pt A","key":"10.1016\/j.yrtph.2026.106041_bib113","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.bbadis.2017.05.007","article-title":"Melanocortin neurons: multiple routes to regulation of metabolism","volume":"1863","author":"Shen","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106041_bib114","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/13813455.2025.2486290","article-title":"Serum levels of omentin and visfatin in patients with metabolic syndrome","volume":"131","author":"Sherly","year":"2025","journal-title":"Arch. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106041_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031109","article-title":"Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor \u03b2","volume":"7","author":"Soriano","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib116","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/ijms.13800","article-title":"Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the west Virginian population","volume":"13","author":"Srikanthan","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.yrtph.2026.106041_bib117","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3706508","article-title":"Role of C-Reactive protein in diabetic inflammation","volume":"2022","author":"Stanimirovic","year":"2022","journal-title":"Mediat. Inflamm."},{"issue":"17","key":"10.1016\/j.yrtph.2026.106041_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713246","article-title":"Increased cell proliferation as a key event in chemical carcinogenesis: application in an integrated approach for the testing and assessment of non-genotoxic carcinogenesis","volume":"24","author":"Strupp","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106041_bib119","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.numecd.2023.09.002","article-title":"Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: a systematic review and meta-analysis","volume":"34","author":"Su","year":"2024","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106041_bib120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s13679-024-00580-1","article-title":"Strengths and limitations of BMI in the diagnosis of obesity: what is the path forward?","volume":"13","author":"Sweatt","year":"2024","journal-title":"Curr. Obes. Rep."},{"issue":"10","key":"10.1016\/j.yrtph.2026.106041_bib121","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/laban1012-277","article-title":"The tale of the watanabe rabbit","volume":"41","year":"2012","journal-title":"Lab Anim (NY)"},{"issue":"11","key":"10.1016\/j.yrtph.2026.106041_bib122","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.2337\/db11-0672","article-title":"Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.yrtph.2026.106041_bib123","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mce.2012.03.021","article-title":"Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPAR\u03b3 activation","volume":"361","author":"Taxvig","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yrtph.2026.106041_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170208","article-title":"The influence of Glucose-dependent insulinotropic polypeptide (GIP) on human adipose tissue and fat metabolism: implications for obesity, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)","volume":"125","author":"Thondam","year":"2020","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib125","first-page":"135","article-title":"Meta-analysis of non-alcoholic fatty liver disease and electromechanical reconstruction of myocardium","volume":"77","author":"Tretyakova","year":"2022","journal-title":"Arch Razi Inst."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106041_bib126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.yrtph.2026.106041_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.107822","article-title":"Structural basis of the activation of PPAR\u03b3 by the plasticizer metabolites MEHP and MINCH","volume":"173","author":"Useini","year":"2023","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2026.106041_bib128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.12688\/openreseurope.18739.1","article-title":"A 2024 inventory of test methods relevant to thyroid hormone system disruption for human health and environmental regulatory hazard assessment","volume":"4","author":"Vergauwen","year":"2024","journal-title":"Open Res. Eur."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib129","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1038\/s41467-024-48956-0","article-title":"Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD","volume":"15","author":"Verschuren","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11995-3","article-title":"Molecular mechanisms involved in the non-monotonic effect of bisphenol-a on ca2+ entry in mouse pancreatic \u03b2-cells","volume":"7","author":"Villar-Pazos","year":"2017","journal-title":"Sci. Rep."},{"issue":"Pt 3","key":"10.1016\/j.yrtph.2026.106041_bib131","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1258\/0004563001899311","article-title":"Measurement of leptin and leptin binding in the human circulation","volume":"37","author":"Wallace","year":"2000","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106041_bib132","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-022-01149-x","article-title":"Signaling pathways in obesity: mechanisms and therapeutic interventions","volume":"7","author":"Wen","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106041_bib134","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"49","key":"10.1016\/j.yrtph.2026.106041_bib135","doi-asserted-by":"crossref","first-page":"31259","DOI":"10.1073\/pnas.2017129117","article-title":"Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease","volume":"117","author":"Yueh","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yrtph.2026.106041_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2023.123030","article-title":"Triclocarban exhibits higher adipogenic activity than triclosan through peroxisome proliferator-activated receptors pathways","volume":"342","author":"Zhang","year":"2024","journal-title":"Environ. Pollut."}],"updated-by":[{"DOI":"10.1016\/j.yrtph.2026.106129","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000}},{"DOI":"10.1016\/j.yrtph.2026.106129","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:50:49Z","timestamp":1774000249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":133,"alternative-id":["S0273230026000140"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106041","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new biomarkers into OECD test guidelines","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106041"}}